Currently, there are 225.66M common shares owned by the public and among those 218.66M shares have been available to trade.
The company’s stock has a 5-day price change of 4.45% and -30.40% over the past three months. RUN shares are trading -28.97% year to date (YTD), with the 12-month market performance down to -39.42% lower. It has a 12-month low price of $5.45 and touched a high of $22.26 over the same period. RUN has an average intraday trading volume of 11.90 million shares. The stock is trading above its simple moving averages at the SMA20, SMA50, and SMA200, as the current price level is off by 2.44%, -7.17%, and -47.35% respectively.
Institutional ownership of Sunrun Inc (NASDAQ: RUN) shares accounts for 110.42% of the company’s 225.66M shares outstanding.
It has a market capitalization of $1.49B and a beta (3y monthly) value of 2.45. The earnings-per-share (ttm) stands at -$12.74. Price movements for the stock have been influenced by the stock’s volatility, which stands at 8.16% over the week and 10.60% over the month.
Analysts forecast that Sunrun Inc (RUN) will achieve an EPS of -0.25 for the current quarter, -0.06 for the next quarter and -0.47 for current fiscal year. The lowest estimate earnings-per-share for the quarter is -0.49 while analysts give the company a high EPS estimate of -0.49. Comparatively, EPS for the current quarter was -0.4 a year ago. Earnings per share for the fiscal year are expected to increase by 93.79%, and -7.70% over the next financial year.
Looking at the support for the RUN, a number of firms have released research notes about the stock. Citigroup stated their Neutral rating for the stock in a research note on April 17, 2025, with the firm’s price target at $7. Jefferies coverage for the Sunrun Inc (RUN) stock in a research note released on March 12, 2025 offered a Hold rating with a price target of $8. TD Cowen was of a view on February 28, 2025 that the stock is Buy, while UBS gave the stock Buy rating on January 10, 2025, issuing a price target of $14- $17. Exane BNP Paribas on their part issued Outperform rating on January 07, 2025.
